TRINETRA › Sectors › Healthcare
Onesource Specialty Pharma Limited (ONESOURCE) — share price, P/E and fundamentals
Onesource Specialty Pharma Limited (NSE: ONESOURCE) closed at ₹1,563.00 on 30 Oct 2026, -14.6% over one year, against a 52-week range of ₹1,057.00 – ₹1,925.00.
From the balance sheet dated 30 Sept 2026: debt-to-equity 0.25.
Against 65 Healthcare peers on NSE: Debt / equity lower than 34% of 64 sector peers.
Key figures
| Last close | ₹1,563.00 (30 Oct 2026) |
|---|---|
| Change 1 month / 6 months / 1 year | -2.0% / -14.3% / -14.6% |
| 52-week low – high | ₹1,057.00 – ₹1,925.00 |
| Debt / equity | 0.25 |
| Current ratio | 1.02 |
| Average daily turnover (50 days) | ₹24.6 cr |
Against Healthcare peers
| Metric | ONESOURCE | Peer median | Percentile |
|---|---|---|---|
| Debt / equity | 0.25 | 0.11 | 66 |
Questions
Does Onesource Specialty Pharma Limited have debt?
Debt-to-equity is 0.25 on the balance sheet dated 30 Sept 2026.
What is ONESOURCE's 52-week high and low?
Over the last 52 weeks to 30 Oct 2026, ONESOURCE traded between ₹1,057.00 and ₹1,925.00.
Other Healthcare stocks
- Sun Pharmaceutical Industries Limited (SUNPHARMA)
- Divi's Laboratories Limited (DIVISLAB)
- Torrent Pharmaceuticals Limited (TORNTPHARM)
- Laurus Labs Limited (LAURUSLABS)
- Zydus Lifesciences Limited (ZYDUSLIFE)
- Apollo Hospitals Enterprise Limited (APOLLOHOSP)
- Dr. Reddy's Laboratories Limited (DRREDDY)
- Cipla Limited (CIPLA)
- Mankind Pharma Limited (MANKIND)
- Aurobindo Pharma Limited (AUROPHARMA)
- Lupin Limited (LUPIN)
- Max Healthcare Institute Limited (MAXHEALTH)
Source: consolidated SEBI Integrated Filing for the quarter ended 30 Sept 2026 and NSE daily closes. Open the interactive terminal view for charts and the full statements.
TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing. Figures are as filed with NSE/SEBI and as of the dates shown; they are not live prices.